Back to funds

Sarissa Capital Management LP

Updated 6 days ago

Managed by Sarissa Capital Management Lp • Latest filing Q3 2026

Portfolio value
$153.2M
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$222.9M
Q1 2026$157.6M
Q2 2026$177.9M
Q3 2026$153.2M

Top holdings

10 positions as of Q3 2026

View filing
I

INNOVIVA INC

Value
$40.1M
Shares
1.89M
% Port
26.18%
I

IRONWOOD PHARMACEUTICALS INC

Value
$36.5M
Shares
9.19M
% Port
23.82%
A

AMARIN CORP PLC

Value
$16.7M
Shares
1.29M
% Port
10.92%
L

LANTHEUS HLDGS INC

Value
$16.6M
Shares
166.9K
% Port
10.85%
N

NEUROCRINE BIOSCIENCES INC

Value
$16.5M
Shares
116.5K
% Port
10.79%
C

CYTOKINETICS INC

Value
$15.1M
Shares
228.6K
% Port
9.84%
B

BIOHAVEN LTD

Value
$7.8M
Shares
582.3K
% Port
5.08%
R

REGENERON PHARMACEUTICALS

Value
$3.2M
Shares
4.2K
% Port
2.07%
V

VOR BIOPHARMA INC

Value
$485K
Shares
25.4K
% Port
0.32%
B

BIOGEN INC

Value
$215K
Shares
950
% Port
0.14%

Explore